A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome

Clinical trial NCT05211830 · COMPLETED

Trial details

NCT number: NCT05211830
Sponsor: Sixera Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Netherton Syndrome

Start date: 2021-12-07
Primary completion: 2025-06-10
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.